SAVIENT PHARMACEUTICALS INC
SVNT
SVNT was delisted on the 16th of October, 2013.
2 hedge funds and large institutions have $0 invested in SAVIENT PHARMACEUTICALS INC in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less capital invested
Capital invested by funds: $231K → $0 (-$231K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSC
Prentiss Smith & Co
Brattleboro,
Vermont
|
-$1K |
SVNT Hedge Fund Activity: Q4 2015 in Review
2 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q4 2015, worth a combined $0 — down 100% from $231K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SVNT and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest seller was Prentiss Smith & Co, exiting entirely with an estimated $1K sold.
- 2 institutional investors held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q4 2015, down from 3 in Q3 2015.
- Funds reported $0 of SAVIENT PHARMACEUTICALS INC stock for Q4 2015, down 100% quarter-over-quarter.
- 1 fund opened new SAVIENT PHARMACEUTICALS INC positions in Q4 2015 and 2 closed out, a net change of -1 holder.
- The largest SAVIENT PHARMACEUTICALS INC seller in Q4 2015 was Prentiss Smith & Co, an estimated $1K sold.
Based on aggregated 13F filings for Q4 2015.